Page 267 - Avian Virology: Current Research and Future Trends
P. 267

260  |  Schat

                                                    95
          AA 97 is unusual for the signature motif. Mutation of C  to serine   resulting in a severe depletion of the thymus cortex at 13 days
          abrogated the DSP activity (Peters et al., 2002), while mutation   pi.  In vitro  infection  of  two  cell  lines  (MSB1  and  1104-X5)
              97
          of C  to serine resulted in a slight decrease of PTPAse activity   also resulted in cell death by apoptosis. Apoptotic bodies were
          but a drastic increase of S/T PPase activity (Peters et al., 2005).   observed in thymocytes from infected chickens and in infected
          Mutation of C  and C  resulted in the elimination of both   cell lines. Subsequent studies using MAb specific for VP3 dem-
                              97
                      95
          phosphatase activities. Virus with the C to S mutation at AA 95   onstrated that this protein was associated with the apoptotic
          or 97 was replication competent but with a drastic reduction in   bodies (Noteborn  et  al., 1994a). Transfection of MSB1 and
                                         1.5
                                               1.7
          viral replication with titres between 10  to 10  TCID /0.1 ml   LSCC-HD11, a myeloid cell line, with the expression vector
                                                      50
          suggesting that the phosphatase activity is important for efficient   pRSV-VP3 also resulted in the induction of apoptosis. Trunca-
          virus replication. Viruses with AA mutations near or in the DSP   tion of VP3 by deleting the 11 codons at the 3′ end of the ORF
          catalytic motif (C87R, R101G, K102D and H103Y) and AA   (VP3tr) resulted in a marked decrease in apoptosis. CEF were
          affecting  the  region with  a high  degree of secondary  structure   resistant to the induction of apoptosis. Twenty-four to 48 hours
          expected to affect the PTPAse activity (R129G, Q131P, R/K/  after infection or transfection VP3 was present in the nucleus as
          K150/151/152G/A/A, D/E161/162G/G, L163P, D169G and    finely distributed granules gradually increasing in size to form
          E186G) were generated and examined in MSB1 cells (Peters   aggregates associated with apoptotic bodies (Noteborn  et  al.,
          et al., 2006). The mutation K102D yielded very low virus titres   1994a). Todd et al. (1994) demonstrated that, in addition to
          comparable to the titres obtained with the mutations at AA 95   VP3, VP1 and VP2 are also present in the apoptotic bodies.
                                                        3
          and 97. All other mutants yielded virus titres between 10  and   VP3 is often referred to as Apoptin, which is derived from
          10  TCID /0.1 ml compared with 10 5.5   TCID /0.1 ml  for   Apoptosis Induction (Pietersen and Noteborn, 2000). Apoptin
            4
                   50
                                                  50
          the wild-type CAU269/7 isolate. Differences in eclipse period,   has been used at least since 1995 by the Noteborn research
          latent period, cell-associated and extra cellular titres were noted   group (Noteborn and Koch, 1995). In this chapter I will use
          between the different mutant and the parent CAU269/7 viruses.   both terms VP3 and Apoptin.
          Two interesting differences are the absence of down regulation   Noteborn et al. (1998c) quoted unpublished data that CAV
          of MHC class I in CAV-infected MSB1 cells and the absence   replication depends on the presence of intact VP3. Wei and
          of VP3 in the nuclei of MSB1 cells infected with the mutant   Schat (unpublished data, 1996) mutated the start codon of VP3
          viruses. These observations suggest that VP2 may play a role in   so that VP3 was no longer produced without changing the VP2
          the transport of VP3 into the nucleus and is a mediator of MHC   AA sequence and confirmed that the mutated virus was no
          class I down-regulation. Using yolk-sac inoculation of 7-day-old   longer able to replicate  in vitro. In an elegant study, Prasetyo
          embryos Peters et al. (2007) noticed that all mutants had reduced   et al.  (2009) also generated  VP3  knock-out  mutants  [CAV/
          pathogenicity at ED 21. In a follow-up study, Kaffashi et al. (2008)   Ap(–)] by mutating the start codon of VP3. Transfection of
          inoculated 1-day-old SPF chicks with different mutants. Chickens   MSB1 cells with CAV/Ap(–) did not yield viral DNA or infec-
          infected with mutant E186G had the highest VN antibody titres   tious virus but virus-like particles were produced. The reverse
          and the authors suggested that this mutant may be a vaccine can-  mutant (CAV/ApRM), in which VP3 was restored, generated
          didate. However, Schat (2009) raised some questions concerning   the same titres as the wild-type virus. They also generated a
                                                                                                                108
          the use of the mutants as vaccine strains. First of all, Scott et al.   point mutation at AA 108 (T108I) generating CAV/ApT I
          (2001) reported that E186G mutations had been found in the   without changing VP2. This  mutation reduced the production
          high passage pathogenic and apathogenic clones 33 and 34. In   of infectious virus significantly suggesting a major role for
          addition, the stability of the mutants in cell culture or chickens is   Threonine at AA 108 (see also Apoptin: use as an anti-cancer
          not clear because a spontaneous mutant was isolated from MSB1   therapy). Co-transfection of MSB1 cells with CAV/Ap(–) with
          cells infected with R129G (Kaffashi et al., 2008).    a plasmid containing wild-type VP3 (pAp/WT) complemented
            As mentioned above, VP2 may be important for the transfer   DNA replication fully but  did not  yield infectious  virus. Co-
                                                                                     108
          of VP3 into the nucleus of MSB1 cells or target cells in chickens   transfection of CAV/ApT I with pAp/WT resulted in DNA
          resulting in the induction of apoptosis. Noteborn and van der Eb   replication and production of infectious virus without changing
          (1998) and Noteborn (2004) suggested that VP2 may also cause   the mutation.
          apoptosis but did not publish the data. Because the VP3 ORF is   Apoptin-like sequences have also been identified in other
          located within the VP2 ORF a mutant VP2 construct is needed   Anelloviridae. Miyata et al. (1999) reported that the sequence
          which eliminates the expression of VP3. Kaffashi et al. (2015)   of TTV TA278 (GenBank accession number AB017610) is
                               –
                           +
          created a pCAT–VP2 VP3  construct which induced apoptosis   similar  to  CAV  in  the  arrangement  of  three  partially  overlap-
          in transfected MSB1 cells. Interestingly a number of the cells   ping ORFs. TTV VP3 showed apoptotic activity in three human
          showed evidence of necrosis rather than apoptosis. The authors   hepatocellular carcinoma cell lines and was named TTV-derived
          suggested that VP2 can also have an anti-apoptotic activity per-  apoptosis-inducing protein (TAIP) by Kooistra et al. (2004).
          haps early during the infection cycle.                Co-transfection of CAV/Ap(–) with TAIP complemented repli-
                                                                cation of CAV/Ap(–) DNA similar to the complementation with
          Viral protein 3                                       pAp/WT (Prasetyo et al., 2009). VP3 of the first human gyro-
          Jeurissen et al. (1992b) reported that  in vivo infection with   virus isolate (HGyV) (Sauvage et al., 2011) has also apoptotic
          CAV caused apoptosis of thymocytes starting at 6 days pi   properties in several human cancer cell lines comparable to CAV
   262   263   264   265   266   267   268   269   270   271   272